Narcobarbital

Narcobarbital
Narcobarbital.svg
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
KEGG
ChEMBL
Chemical and physical data
Formula C11H15BrN2O3
Molar mass 303.152 g/mol g·mol−1
3D model (JSmol)
  (verify)

Narcobarbital (Pronarcon) is a barbiturate derivative developed in 1932 by Carl Heinrich Friedrich Boedecker and Heinrich Gruber Schoneberg, assignors to the firm J. D. Riedel-E. de Haën AG, Berlin, Germany. Later, in 1937, may, was patented in United States.[1] It is an N-methylated derivative of propallylonal and has similar sedative effects. It is still used in veterinary medicine for inducing surgical anaesthesia.[2]

References[edit]

  1. ^ US Patent 2080071
  2. ^ N/A (1999). “Position Paper on availability of Veterinary Medicines agreed on 17 March 1999” (PDF (Public access)). Committee For Veterinary Medicinal Products: 3–8.